Moody Lynn & Lieberson’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-2,202
Closed -$290K – 213
2017
Q3
$290K Sell
2,202
-41
-2% -$5.51K 0.04% 192
2017
Q2
$299K Buy
2,243
+252
+13% +$34K 0.04% 191
2017
Q1
$268K Buy
1,991
+4
+0.2% +$518 0.04% 156
2016
Q4
$238K Sell
1,987
-7
-0.4% -$826 0.03% 159
2016
Q3
$250K Sell
1,994
-43
-2% -$5.63K 0.04% 156
2016
Q2
$282K Buy
2,037
+40
+2% +$5.19K 0.05% 138
2016
Q1
$252K Sell
1,997
-1,372
-41% -$174K 0.04% 147
2015
Q4
$427K Buy
3,369
+144
+4% +$17.9K 0.07% 131
2015
Q3
$373K Buy
+3,225
New +$362K 0.07% 132

Other funds holding CLX

Moody Lynn & Lieberson's CLX Position: Q4 2017 in Review

Moody Lynn & Lieberson sold out of Clorox (CLX) in Q4 2017, closing a stake of 2,202 shares — an estimated $290K sold.

Moody Lynn & Lieberson first reported a position in CLX in Q3 2015 and held it in 9 quarters. The position peaked at $427K in Q4 2015. 932 funds tracked by Wall St. Rank hold CLX as of Q4 2017.

  • Moody Lynn & Lieberson reported no remaining Clorox position as of Q4 2017 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 2,202 Clorox shares in Q4 2017, an estimated $290K.
  • Moody Lynn & Lieberson first reported a position in Clorox in Q3 2015 and held it in 9 quarters.
  • Moody Lynn & Lieberson's Clorox position peaked at $427K in Q4 2015.
  • 932 funds tracked by Wall St. Rank held Clorox as of Q4 2017.

Based on Moody Lynn & Lieberson's 13F filing for Q4 2017, filed 2 Feb 2018.